img

Global Psoriatic Arthritis Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Psoriatic Arthritis Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Psoriatic Arthritis Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Psoriatic Arthritis Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Mild Psoriatic Arthritis and Moderate Psoriatic Arthritis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Psoriatic Arthritis Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Psoriatic Arthritis Drugs key manufacturers include Abbvie, Janssen, Amgen, Pfizer, Eli-Lilly and Celgene, etc. Abbvie, Janssen, Amgen are top 3 players and held % sales share in total in 2022.
Psoriatic Arthritis Drugs can be divided into TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers and Other, etc. TNF Inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022.
Psoriatic Arthritis Drugs is widely used in various fields, such as Mild Psoriatic Arthritis, Moderate Psoriatic Arthritis and Severe Psoriatic Arthritis,, etc. Mild Psoriatic Arthritis provides greatest supports to the Psoriatic Arthritis Drugs industry development. In 2022, global % sales of Psoriatic Arthritis Drugs went into Mild Psoriatic Arthritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Psoriatic Arthritis Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbvie
Janssen
Amgen
Pfizer
Eli-Lilly
Celgene
Segment by Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other

Segment by Application


Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Psoriatic Arthritis Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Psoriatic Arthritis Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Psoriatic Arthritis Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Psoriatic Arthritis Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Psoriatic Arthritis Drugs introduction, etc. Psoriatic Arthritis Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Psoriatic Arthritis Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Psoriatic Arthritis Drugs Market Overview
1.1 Psoriatic Arthritis Drugs Product Overview
1.2 Psoriatic Arthritis Drugs Market Segment by Type
1.2.1 TNF Inhibitors
1.2.2 PDE4 Inhibitors
1.2.3 Interleukin Blockers
1.2.4 Other
1.3 Global Psoriatic Arthritis Drugs Market Size by Type
1.3.1 Global Psoriatic Arthritis Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Psoriatic Arthritis Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Psoriatic Arthritis Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Psoriatic Arthritis Drugs Sales Breakdown by Type (2018-2024)
2 Global Psoriatic Arthritis Drugs Market Competition by Company
2.1 Global Top Players by Psoriatic Arthritis Drugs Sales (2018-2024)
2.2 Global Top Players by Psoriatic Arthritis Drugs Revenue (2018-2024)
2.3 Global Top Players by Psoriatic Arthritis Drugs Price (2018-2024)
2.4 Global Top Manufacturers Psoriatic Arthritis Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Psoriatic Arthritis Drugs Market Competitive Situation and Trends
2.5.1 Psoriatic Arthritis Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Psoriatic Arthritis Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psoriatic Arthritis Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Psoriatic Arthritis Drugs Market
2.8 Key Manufacturers Psoriatic Arthritis Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Psoriatic Arthritis Drugs Status and Outlook by Region
3.1 Global Psoriatic Arthritis Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Psoriatic Arthritis Drugs Historic Market Size by Region
3.2.1 Global Psoriatic Arthritis Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Psoriatic Arthritis Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Psoriatic Arthritis Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Psoriatic Arthritis Drugs Forecasted Market Size by Region
3.3.1 Global Psoriatic Arthritis Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Psoriatic Arthritis Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Psoriatic Arthritis Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Psoriatic Arthritis Drugs by Application
4.1 Psoriatic Arthritis Drugs Market Segment by Application
4.1.1 Mild Psoriatic Arthritis
4.1.2 Moderate Psoriatic Arthritis
4.1.3 Severe Psoriatic Arthritis
4.2 Global Psoriatic Arthritis Drugs Market Size by Application
4.2.1 Global Psoriatic Arthritis Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Psoriatic Arthritis Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Psoriatic Arthritis Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Psoriatic Arthritis Drugs Sales Breakdown by Application (2018-2024)
5 North America Psoriatic Arthritis Drugs by Country
5.1 North America Psoriatic Arthritis Drugs Historic Market Size by Country
5.1.1 North America Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Psoriatic Arthritis Drugs Sales in Value by Country (2018-2024)
5.2 North America Psoriatic Arthritis Drugs Forecasted Market Size by Country
5.2.1 North America Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Psoriatic Arthritis Drugs Sales in Value by Country (2024-2034)
6 Europe Psoriatic Arthritis Drugs by Country
6.1 Europe Psoriatic Arthritis Drugs Historic Market Size by Country
6.1.1 Europe Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Psoriatic Arthritis Drugs Sales in Value by Country (2018-2024)
6.2 Europe Psoriatic Arthritis Drugs Forecasted Market Size by Country
6.2.1 Europe Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Psoriatic Arthritis Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Psoriatic Arthritis Drugs by Region
7.1 Asia-Pacific Psoriatic Arthritis Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Psoriatic Arthritis Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Psoriatic Arthritis Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Psoriatic Arthritis Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Psoriatic Arthritis Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Psoriatic Arthritis Drugs Sales in Value by Region (2024-2034)
8 Latin America Psoriatic Arthritis Drugs by Country
8.1 Latin America Psoriatic Arthritis Drugs Historic Market Size by Country
8.1.1 Latin America Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Psoriatic Arthritis Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Psoriatic Arthritis Drugs Forecasted Market Size by Country
8.2.1 Latin America Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Psoriatic Arthritis Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Psoriatic Arthritis Drugs by Country
9.1 Middle East and Africa Psoriatic Arthritis Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Psoriatic Arthritis Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Psoriatic Arthritis Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Psoriatic Arthritis Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Psoriatic Arthritis Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Psoriatic Arthritis Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Psoriatic Arthritis Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbvie
10.1.1 Abbvie Company Information
10.1.2 Abbvie Introduction and Business Overview
10.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Abbvie Psoriatic Arthritis Drugs Products Offered
10.1.5 Abbvie Recent Development
10.2 Janssen
10.2.1 Janssen Company Information
10.2.2 Janssen Introduction and Business Overview
10.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Janssen Psoriatic Arthritis Drugs Products Offered
10.2.5 Janssen Recent Development
10.3 Amgen
10.3.1 Amgen Company Information
10.3.2 Amgen Introduction and Business Overview
10.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Amgen Psoriatic Arthritis Drugs Products Offered
10.3.5 Amgen Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Psoriatic Arthritis Drugs Products Offered
10.4.5 Pfizer Recent Development
10.5 Eli-Lilly
10.5.1 Eli-Lilly Company Information
10.5.2 Eli-Lilly Introduction and Business Overview
10.5.3 Eli-Lilly Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Eli-Lilly Psoriatic Arthritis Drugs Products Offered
10.5.5 Eli-Lilly Recent Development
10.6 Celgene
10.6.1 Celgene Company Information
10.6.2 Celgene Introduction and Business Overview
10.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Celgene Psoriatic Arthritis Drugs Products Offered
10.6.5 Celgene Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Psoriatic Arthritis Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Psoriatic Arthritis Drugs Industrial Chain Analysis
11.4 Psoriatic Arthritis Drugs Market Dynamics
11.4.1 Psoriatic Arthritis Drugs Industry Trends
11.4.2 Psoriatic Arthritis Drugs Market Drivers
11.4.3 Psoriatic Arthritis Drugs Market Challenges
11.4.4 Psoriatic Arthritis Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Psoriatic Arthritis Drugs Distributors
12.3 Psoriatic Arthritis Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of TNF Inhibitors
Table 2. Major Company of PDE4 Inhibitors
Table 3. Major Company of Interleukin Blockers
Table 4. Major Company of Other
Table 5. Global Psoriatic Arthritis Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (K MT)
Table 7. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Psoriatic Arthritis Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Psoriatic Arthritis Drugs Price by Type (2018-2024) & (USD/MT)
Table 11. Global Psoriatic Arthritis Drugs Sales by Type (2024-2034) & (K MT)
Table 12. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Psoriatic Arthritis Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Psoriatic Arthritis Drugs Price by Type (2024-2034) & (USD/MT)
Table 16. North America Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (K MT)
Table 17. North America Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Psoriatic Arthritis Drugs Sales (K MT) by Type (2018-2024)
Table 19. Europe Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Psoriatic Arthritis Drugs Sales (K MT) by Type (2018-2024)
Table 21. Asia-Pacific Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Psoriatic Arthritis Drugs Sales (K MT) by Type (2018-2024)
Table 23. Latin America Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Psoriatic Arthritis Drugs Sales (K MT) by Type (2018-2024)
Table 25. Middle East and Africa Psoriatic Arthritis Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Psoriatic Arthritis Drugs Sales by Company (2018-2024) & (K MT)
Table 27. Global Psoriatic Arthritis Drugs Sales Share by Company (2018-2024)
Table 28. Global Psoriatic Arthritis Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Psoriatic Arthritis Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Psoriatic Arthritis Drugs Price by Company (2018-2024) & (USD/MT)
Table 31. Global Psoriatic Arthritis Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Psoriatic Arthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psoriatic Arthritis Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Psoriatic Arthritis Drugs Market
Table 35. Key Manufacturers Psoriatic Arthritis Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Psoriatic Arthritis Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Psoriatic Arthritis Drugs Sales by Region (2018-2024) & (K MT)
Table 39. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Psoriatic Arthritis Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 43. Global Psoriatic Arthritis Drugs Sales by Region (2024-2034) & (K MT)
Table 44. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Psoriatic Arthritis Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 48. Global Psoriatic Arthritis Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Psoriatic Arthritis Drugs Sales by Application (2018-2024) & (K MT)
Table 50. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Psoriatic Arthritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Psoriatic Arthritis Drugs Price by Application (2018-2024) & (USD/MT)
Table 54. Global Psoriatic Arthritis Drugs Sales by Application (2024-2034) & (K MT)
Table 55. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Psoriatic Arthritis Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Psoriatic Arthritis Drugs Price by Application (2024-2034) & (USD/MT)
Table 59. North America Psoriatic Arthritis Drugs Sales by Application (2018-2024) (K MT)
Table 60. North America Psoriatic Arthritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Psoriatic Arthritis Drugs Sales by Application (2018-2024) (K MT)
Table 62. Europe Psoriatic Arthritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Psoriatic Arthritis Drugs Sales by Application (2018-2024) (K MT)
Table 64. Asia-Pacific Psoriatic Arthritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Psoriatic Arthritis Drugs Sales by Application (2018-2024) (K MT)
Table 66. Latin America Psoriatic Arthritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Psoriatic Arthritis Drugs Sales by Application (2018-2024) (K MT)
Table 68. Middle East and Africa Psoriatic Arthritis Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (K MT)
Table 70. North America Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (K MT)
Table 74. North America Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (K MT)
Table 78. Europe Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (K MT)
Table 82. Europe Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Psoriatic Arthritis Drugs Sales by Region (2018-2024) & (K MT)
Table 86. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Psoriatic Arthritis Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Psoriatic Arthritis Drugs Sales by Region (2024-2034) & (K MT)
Table 90. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Psoriatic Arthritis Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (K MT)
Table 94. Latin America Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (K MT)
Table 98. Latin America Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (K MT)
Table 102. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (K MT)
Table 106. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Psoriatic Arthritis Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Abbvie Company Information
Table 110. Abbvie Introduction and Business Overview
Table 111. Abbvie Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 112. Abbvie Psoriatic Arthritis Drugs Product
Table 113. Abbvie Recent Development
Table 114. Janssen Company Information
Table 115. Janssen Introduction and Business Overview
Table 116. Janssen Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 117. Janssen Psoriatic Arthritis Drugs Product
Table 118. Janssen Recent Development
Table 119. Amgen Company Information
Table 120. Amgen Introduction and Business Overview
Table 121. Amgen Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 122. Amgen Psoriatic Arthritis Drugs Product
Table 123. Amgen Recent Development
Table 124. Pfizer Company Information
Table 125. Pfizer Introduction and Business Overview
Table 126. Pfizer Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 127. Pfizer Psoriatic Arthritis Drugs Product
Table 128. Pfizer Recent Development
Table 129. Eli-Lilly Company Information
Table 130. Eli-Lilly Introduction and Business Overview
Table 131. Eli-Lilly Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 132. Eli-Lilly Psoriatic Arthritis Drugs Product
Table 133. Eli-Lilly Recent Development
Table 134. Celgene Company Information
Table 135. Celgene Introduction and Business Overview
Table 136. Celgene Psoriatic Arthritis Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 137. Celgene Psoriatic Arthritis Drugs Product
Table 138. Celgene Recent Development
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Psoriatic Arthritis Drugs Market Trends
Table 142. Psoriatic Arthritis Drugs Market Drivers
Table 143. Psoriatic Arthritis Drugs Market Challenges
Table 144. Psoriatic Arthritis Drugs Market Restraints
Table 145. Psoriatic Arthritis Drugs Distributors List
Table 146. Psoriatic Arthritis Drugs Downstream Customers
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Psoriatic Arthritis Drugs Product Picture
Figure 2. Global Psoriatic Arthritis Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Psoriatic Arthritis Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Psoriatic Arthritis Drugs Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of TNF Inhibitors
Figure 6. Global TNF Inhibitors Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of PDE4 Inhibitors
Figure 8. Global PDE4 Inhibitors Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Interleukin Blockers
Figure 10. Global Interleukin Blockers Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Global Psoriatic Arthritis Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Psoriatic Arthritis Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Psoriatic Arthritis Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Psoriatic Arthritis Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Psoriatic Arthritis Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Psoriatic Arthritis Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Psoriatic Arthritis Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Psoriatic Arthritis Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Psoriatic Arthritis Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Psoriatic Arthritis Drugs Revenue in 2022
Figure 27. Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Mild Psoriatic Arthritis
Figure 29. Global Mild Psoriatic Arthritis Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Moderate Psoriatic Arthritis
Figure 31. Global Moderate Psoriatic Arthritis Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Product Picture of Severe Psoriatic Arthritis
Figure 33. Global Severe Psoriatic Arthritis Sales YoY Growth (2018-2034) & (K MT)
Figure 34. Global Psoriatic Arthritis Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Psoriatic Arthritis Drugs Sales Market Share by Application in 2022 & 2034
Figure 36. North America Psoriatic Arthritis Drugs Sales Market Share in Volume by Application in 2022
Figure 37. North America Psoriatic Arthritis Drugs Sales Market Share in Value by Application in 2022
Figure 38. Europe Psoriatic Arthritis Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Europe Psoriatic Arthritis Drugs Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Psoriatic Arthritis Drugs Sales Market Share in Value by Application in 2022
Figure 42. Latin America Psoriatic Arthritis Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Psoriatic Arthritis Drugs Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Psoriatic Arthritis Drugs Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Psoriatic Arthritis Drugs Manufacturing Cost Structure
Figure 47. Psoriatic Arthritis Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed